Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 19


Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.

Di Narzo AF, Tejpar S, Rossi S, Yan P, Popovici V, Wirapati P, Budinska E, Xie T, Estrella H, Pavlicek A, Mao M, Martin E, Scott W, Bosman FT, Roth A, Delorenzi M.

J Natl Cancer Inst. 2014 Sep 22;106(10). pii: dju247. doi: 10.1093/jnci/dju247. Print 2014 Oct.


PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

Missiaglia E, Williamson D, Chisholm J, Wirapati P, Pierron G, Petel F, Concordet JP, Thway K, Oberlin O, Pritchard-Jones K, Delattre O, Delorenzi M, Shipley J.

J Clin Oncol. 2012 May 10;30(14):1670-7. doi: 10.1200/JCO.2011.38.5591. Epub 2012 Mar 26.


Detecting epistasis with restricted response patterns in pairs of biallelic loci.

Wirapati P, Forner K, Delgado-Vega A, Alarcón-Riquelme M, Delorenzi M, Wojcik J.

Ann Hum Genet. 2011 Jan;75(1):133-45. doi: 10.1111/j.1469-1809.2010.00625.x. Epub 2010 Nov 30.


Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue.

Antonov J, Popovici V, Delorenzi M, Wirapati P, Baltzer A, Oberli A, Thürlimann B, Giobbie-Hurder A, Viale G, Altermatt HJ, Aebi S, Jaggi R.

BMC Cancer. 2010 Feb 9;10:37. doi: 10.1186/1471-2407-10-37.


Relationship between estrogen receptor alpha location and gene induction reveals the importance of downstream sites and cofactors.

Parisi F, Sonderegger B, Wirapati P, Delorenzi M, Naef F.

BMC Genomics. 2009 Aug 18;10:381. doi: 10.1186/1471-2164-10-381.


Chromosomal number aberrations and transformation in adult mouse retinal stem cells in vitro.

Djojosubroto M, Bollotte F, Wirapati P, Radtke F, Stamenkovic I, Arsenijevic Y.

Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5975-87. doi: 10.1167/iovs.08-3091. Epub 2009 Jul 23.


A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6.

Bengtsson H, Wirapati P, Speed TP.

Bioinformatics. 2009 Sep 1;25(17):2149-56. doi: 10.1093/bioinformatics/btp371. Epub 2009 Jun 17.


Selecting control genes for RT-QPCR using public microarray data.

Popovici V, Goldstein DR, Antonov J, Jaggi R, Delorenzi M, Wirapati P.

BMC Bioinformatics. 2009 Feb 2;10:42. doi: 10.1186/1471-2105-10-42.


Impact of normalization on miRNA microarray expression profiling.

Pradervand S, Weber J, Thomas J, Bueno M, Wirapati P, Lefort K, Dotto GP, Harshman K.

RNA. 2009 Mar;15(3):493-501. doi: 10.1261/rna.1295509. Epub 2009 Jan 28.


A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.

Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, André S, Piccart M, Campone M, Brain E, Macgrogan G, Petit T, Jassem J, Bibeau F, Blot E, Bogaerts J, Aguet M, Bergh J, Iggo R, Delorenzi M.

Nat Med. 2009 Jan;15(1):68-74. doi: 10.1038/nm.1908. Epub 2009 Jan 4. Erratum in: Nat Med. 2009 Feb;15(2):220. Wirapati, Pratyakasha [corrected to Wirapati, Pratyaksha].


Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes.

Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M, Sotiriou C.

Clin Cancer Res. 2008 Aug 15;14(16):5158-65. doi: 10.1158/1078-0432.CCR-07-4756.


Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

Breast Cancer Res. 2008;10(4):R65. doi: 10.1186/bcr2124. Epub 2008 Jul 28.


Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.

Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidone MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C.

BMC Genomics. 2008 May 22;9:239. doi: 10.1186/1471-2164-9-239.


Affymetrix Whole-Transcript Human Gene 1.0 ST array is highly concordant with standard 3' expression arrays.

Pradervand S, Paillusson A, Thomas J, Weber J, Wirapati P, Hagenbüchle O, Harshman K.

Biotechniques. 2008 May;44(6):759-62. doi: 10.2144/000112751.


Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome.

Vuaroqueaux V, Urban P, Labuhn M, Delorenzi M, Wirapati P, Benz CC, Flury R, Dieterich H, Spyratos F, Eppenberger U, Eppenberger-Castori S.

Breast Cancer Res. 2007;9(3):R33.


Identifying synergistic regulation involving c-Myc and sp1 in human tissues.

Parisi F, Wirapati P, Naef F.

Nucleic Acids Res. 2007;35(4):1098-107. Epub 2007 Jan 30.


Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.

Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ, Benz C, Eppenberger U, Eppenberger-Castori S.

J Clin Oncol. 2006 Sep 10;24(26):4245-53.


Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M.

J Natl Cancer Inst. 2006 Feb 15;98(4):262-72.


Meiotic breakpoint mapping of a proposed X linked visual loss susceptibility locus in Leber's hereditary optic neuropathy.

Handoko HY, Wirapati PJ, Sudoyo HA, Sitepu M, Marzuki S.

J Med Genet. 1998 Aug;35(8):668-71.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk